Log in to save to my catalogue

Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy

Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6c1cbd8acb2f42149db4a8201852deb6

Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy

About this item

Full title

Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2017-12, Vol.8 (1), p.1954-15, Article 1954

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Subunit vaccines have been investigated in over 1000 clinical trials of cancer immunotherapy, but have shown limited efficacy. Nanovaccines may improve efficacy but have rarely been clinically translated. By conjugating molecular vaccines with Evans blue (EB) into albumin-binding vaccines (AlbiVax), here we develop clinically promising albumin/Albi...

Alternative Titles

Full title

Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6c1cbd8acb2f42149db4a8201852deb6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6c1cbd8acb2f42149db4a8201852deb6

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-017-02191-y

How to access this item